Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 47 (6) , 261-264
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST SubstudyJournal of Clinical Oncology, 2016
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology, 2015
- Adjuvant Ovarian Suppression in Premenopausal Breast CancerNew England Journal of Medicine, 2015
- Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast CancerNew England Journal of Medicine, 2014
- Efficacy and Safety of Leuprolide Acetate 3-Month Depot 11.25 Milligrams or 30 Milligrams for the Treatment of Central Precocious PubertyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate CancerUrologia Internationalis, 2006
- FAILURE TO ACHIEVE CASTRATE LEVELS OF TESTOSTERONE DURING LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY: THE CASE FOR MONITORING SERUM TESTOSTERONE AND A TREATMENT DECISION ALGORITHMJournal of Urology, 2000
- Subcutaneous Administration of a Depot Gonadotropin-Releasing Hormone Agonist Induces Profound Reproductive Axis Suppression in WomenFertility and Sterility, 1998
- Persistent elevation of serum oestradiol levels by functional ovarian cysts despite effective pituitary desensitization with GnRH agonistsClinical Endocrinology, 1994
- Long Term Effects of Administration of a Gonadotropin Releasing Hormone Superagonist Analog in Men with Prostatic CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 1984